TFAM and COVID-19: In line with our current report, studies have shown that TFAM deficiency causes mitochondria damage and mtDNA depletion, which would in turn lead to cellular energetic insufficiency, oxidative stress, and mtDNA stress-mediated inflammatory responses underpinning the development of severe pulmonary diseases such as influenza pneumonia and COVID-19 [61–63].